Word count of abstract: 240 1 OBJECTIVE -We conducted a nested case-control investigation to examine if elevated baseline concentrations of cystatin-C predicted progression from normoglycaemia to prediabetes over 6 years of follow-up from the Western New York Health Study.
Recent evidence from randomized clinical trials (1,2) among people with prediabetes have provided convincing evidence that early intervention can significantly delay or prevent the progression to type 2 diabetes. The identification of those with prediabetes is assuming greater importance (3) especially in light of the fact that approximately 35 million adults aged 40-74 years old in the United States have prediabetes defined as impaired fasting glucose (4) . Microalbuminuria occurs frequently in nondiabetic subjects and places them at increased risk for cardiovascular disease (5-7). The mechanisms behind this observation are poorly understood, however. Albuminuria may reflect underlying vascular damage (8) , hypertension (9, 10) endothelial dysfunction (11, 12) and/or low-grade inflammation (13) .
A large percentage of type 2 individuals pass through a period of prediabetes (14) and may experience early renal dysfunction e.g., a glomerular filtration rate (GFR) above 60 ml/minute per 1.73m 2 . Currently used estimating equations are poor at identifying early renal impairment and better indices are of great interest (15, 16) . Recently, several studies have suggested that cystatin-C levels may be a more sensitive marker of early renal impairment than either albuminuria or serum creatinine concentration (17) (18) (19) (20) .
Therefore, a better understanding of a putative role for cystatin-C in the etiology of prediabetes could shed light on the renal/heart disease connection (21) . Given the reported superiority of cystatin C over conventional measures of renal function, we hypothesized that cystatin-C would predict progression to prediabetes independent of serum creatinine or estimated GFR. We also investigated the role of intervening mechanisms including hypertension, insulin resistance, endothelial dysfunction and inflammation.
RESEARCH DESIGN AND METHODS

Participants
The study design and methodology of this community-based investigation have been previously published (22, 23 mg/dl at the follow-up examination. All cases (n=91) were matched 1:3 to control participants based upon sex, race/ethnicity and year of study enrollment. All controls had fasting glucose levels < 100 mg/dl at both baseline and follow-up examinations.
Laboratory Methods
Fasting glucose concentrations were determined by the glucose oxidase method assayed with a nephelometric immunoassay using a monospecific antiserum to human albumin. Creatinine concentration was determined using the modified Jaffe method. The urinary albumin to creatinine ratio (ACR mg albumin / g creatinine) was calculated and utilized as a surrogate of albumin excretion rate (26) . Intraclass correlation coefficients among duplicate samples exceeded 0.95.
Over ninety-four percent of the values were below 30 mg/g. Glomerular filtration rate was estimated (eGFR) using the four variable formula from the Modification of Dietary Restriction in Diabetes Study (27, 28) . This formula is: eGFR = 186.3
x (Serum creatinine concentration Likelihood ratio tests were conducted to test for statistical interactions by comparing the log likelihood between the two nested models, one with only the main effects, and the other with both the main effects and the interaction terms in the model. No significant effect-modification was noted. All statistical tests were two-sided and a p-value of < 0.05 was considered statistically significant.
Analyses were carried out using the SPSS for Windows version 14.0 (Chicago, IL). Table 1 presents selected characteristics at baseline for cases and controls.
RESULTS
There were 91 cases of prediabetes that were matched with 273 control participants. Those who progressed to become cases of prediabetes were significantly older, more obese and heavier lifetime smokers than the controls (P < 0.05 for each). Cases were also significantly more insulin resistant at baseline and displayed higher mean concentrations of cystatin-C. No significant differences were observed for serum creatinine or eGFR. Fasting plasma glucose was higher among the cases than controls (94.3 vs 90.5 mg/dl; P < 0.001). Cases had significantly less formal education and a higher prevalence of a family history of diabetes, and were more likely to be hypertensive at the baseline examination. Compared to the controls, cases were more likely to have been smokers consumers of alcohol (P < 0.05). Table 2 presents the results of conditional logistic regression also adjusted for age. As shown, a positive family history of type 2 diabetes, hypertension, cigarette smoking, and HOMA-IR were each related to prediabetic status. A BMI ≥ 27 kg/m 2 was associated with a 62 percent excess risk, although the 95% CI included unity. Neither serum creatinine nor ACR were found to predict prediabetic status. Consideration of continuous forms for these variables also provided no evidence of association with prediabetic status.
The results of the multiple conditional logistic regression analyses for cystatin-C and odds of developing prediabetes are displayed in Table 3 . Models were conditioned on the matching variables of sex, race, and year of study enrollment. Model one was further adjusted for age and model 2 was fullyadjusted for age and several of the explanatory variables shown in table 2 including eGFR. Comparing the highest quintile of cystatin-C to the lowest 80% revealed an age-adjusted odds ratio of 5.08 (95%CI: 2.69, 9.58). After consideration of the putative risk factors for prediabetes in model 2, the odds ratio was attenuated to 3.04 (95% CI: 1.34, 6.89) but remained highly statistically significant (P ≤ 0.01). No change in the effect size for cystatin-C was observed when serum creatinine (or ACR) was substituted for eGFR.
In order to investigate possible intervening mechanisms, we examined the association between cystatin-C, serum creatinine, urinary ACR, and several biomarkers of inflammation (hs-CRP and IL-6) and endothelial dysfunction (E-selectin and sICAM) among the control group (table 4) . As shown, cystatin-C was significantly, though modestly associated with hs-CRP, Eselectin, sICAM, and IL-6 (P < 0.001 for each). Cystatin-C was not significantly correlated with ACR (r s = -0.007) but was significantly correlated with serum creatinine (r s = 0.446; P < 0.001) and eGFR (r s = -0.384; P <0.01).
Secondary analyses were performed where biomarkers of inflammation or endothelial dysfunction were each considered one by one. Neither adjustment for E-selectin, nor sICAM had virtually any effect on the results.
Consideration of hs-CRP, IL-6 or eGFR likewise failed to materially alter the original findings.
CONCLUSION
In this investigation, we found an approximate three-fold increased risk of progression to prediabetes among those in the highest quintile of cystatin-C in a population free of diabetes and known cardiovascular disease. This association was independent of obesity, baseline glucose, eGFR (or serum creatinine), ACR, and other explanatory variables. These results extend previous observations for cardiovascular disease (17) (18) (19) (20) 29) to include the early diabetic stage.
Several studies have examined proteinuria or microalbuminuria in relation to future health events in populations with type 1 diabetes, type 2 diabetes, and apparently healthy subjects. Proteinuria is a risk factor for end-stage renal disease among those with type 1 diabetes, and microalbuminuria has been associated with increased CVD mortality among both nondiabetic and type 2 diabetic persons (30) (31) (32) (33) . Cystatin C is also raised in the diabetic state but has been related to increased risk of mortality independent of diabetic status (18) .
The results of this study support the hypothesis that cystatin -C may be The prevalence of hypertension at baseline was higher among the future case group than the matched controls. We do not know whether blood pressure rose before or concomitantly with cystatin C levels. Cigarette smoking and intensity of smoking were also higher among cases than controls. Smoking has been identified in some studies to predict microalbuminuria among type 1 individuals (30). Hyperinsulinemia/insulin resistance has also been associated with albuminuria in several reports (31) (32) (33) . Our results confirmed these associations but suggest further that the effect of cystatin C on risk of progression was largely independent of hypertension, smoking and HOMA-IR.
Preclinical kidney disease has been suggested to be related to underlying processes unrelated to the kidney per se (34) . Our data indicated that cystatin-C was significantly correlated with several markers of inflammation including hs-CRP and IL-6. However in secondary analyses that considered these biomarkers, the results remained unaltered. The same held true for markers of endothelial function (E-selectin and sICAM (data not shown). These results are consistent with findings from the Cardiovascular Health Study (35) but suggest further that the effect of cystatin-C on risk of progression to prediabetes cannot be solely explained by inflammation or endothelial dysfunction. We did not find an association between urinary ACR and cystatin-C, likely due to the narrow distribution of ACR in our study population and/or the use of a single casual urine sample.
Several limitations are deserving of comment. We did not use an oral glucose tolerance test thus some of the study participants classified as prediabetic cases at the follow-up examination, may have undetected type 2 diabetes (36).
However, fasting glucose measures are more highly correlated over time than the 2-hour postchallenge glucose level and upon repeat testing many with newly detected type 2 diabetes are found to "revert" to either impaired glucose tolerance or normal (37) (38) (39) . We also had only single measures of both cystatin-C and glucose. This random error would serve however, to bias our results towards the null. The strengths of the study include the selection of a community-based population, detailed measures of several important covariates, and the assessment of possible intermediate factors including
hypertension, smoking, insulin resistance, inflammation, and endothelial dysfunction. Our results, however, need to be replicated, particularly among minority populations. Although observational studies cannot prove causality, the magnitude of the effect size and statistical control for many covariates make our findings compelling and important.
Cystatin-C has been shown recently to predict incident coronary heart disease events (40) , suggesting that the renal/heart disease connection may share common mechanisms. Our findings provide an important new avenue for future research suggesting that mild renal impairment may occur early in the natural history of diabetes. The possibility that cystatin C may also predict type 2 diabetes remains to be tested, but if proved correct, raises intriguing possibilities for prevention and treatment as it might be fruitful to look for markers of renal impairment early in the course of hyperglycemia that could be modified by lifestyle and hygienic measures. OR and CI from conditional logistic regression using matched cases and controls.
All models are conditioned on sex, race, and year of study enrollment.
Model 1 adjusted for age. Model 2 adjusted for age, BMI (kg/m 2 ), family history of diabetes (no,yes), current smoker (never,ever), lifetime packyears, fasting glucose (mg/dl), current drinker (no,yes), baseline hypertension(no,yes), HOMA-IR, and eGFR ** p<.01, *** p<.001 
